Safety Study of Attenuated Vaccinia Virus (GL-ONC1)With Combination Therapy in Head & Neck Cancer
NCT01584284
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
19
Enrollment
INDUSTRY
Sponsor class
Conditions
Cancer of Head and Neck
Interventions
BIOLOGICAL:
GL-ONC1
Sponsor
Genelux Corporation